Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab.


The Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland. Electronic address: [Email]


To investigate characteristics associated with visual and anatomic outcomes in branch and central retinal vein occlusion (BRVO and CRVO) patients treated with ranibizumab.

OUR Recent Articles